Nu Skin Enterprises Management
Management criteria checks 2/4
Nu Skin Enterprises' CEO is Ryan Napierski, appointed in Mar 2017, has a tenure of 7.67 years. total yearly compensation is $5.84M, comprised of 17% salary and 83% bonuses, including company stock and options. directly owns 0.21% of the company’s shares, worth $790.91K. The average tenure of the management team and the board of directors is 12.1 years and 12.1 years respectively.
Key information
Ryan Napierski
Chief executive officer
US$5.8m
Total compensation
| CEO salary percentage | 17.0% |
| CEO tenure | 7.7yrs |
| CEO ownership | 0.2% |
| Management average tenure | 12.1yrs |
| Board average tenure | 12.1yrs |
Recent management updates
Recent updates
Does Nu Skin Enterprises (NYSE:NUS) Have A Healthy Balance Sheet?
Nov 12
Nu Skin: New Products And Ongoing Digital Transformation Imply Undervaluation
Nov 12The Market Doesn't Like What It Sees From Nu Skin Enterprises, Inc.'s (NYSE:NUS) Revenues Yet As Shares Tumble 27%
Oct 04Nu Skin Enterprises' (NYSE:NUS) Returns On Capital Not Reflecting Well On The Business
Aug 31Insufficient Growth At Nu Skin Enterprises, Inc. (NYSE:NUS) Hampers Share Price
Aug 13Nu Skin Enterprises, Inc.'s (NYSE:NUS) CEO Might Not Expect Shareholders To Be So Generous This Year
May 30Is Nu Skin Enterprises (NYSE:NUS) Using Too Much Debt?
May 13Capital Allocation Trends At Nu Skin Enterprises (NYSE:NUS) Aren't Ideal
Mar 28Nu Skin: A Sell Signal Amidst Industry Decline And Strategic Uncertainty
Mar 04We Think You Can Look Beyond Nu Skin Enterprises' (NYSE:NUS) Lackluster Earnings
Feb 22Nu Skin Enterprises' (NYSE:NUS) Dividend Will Be Reduced To $0.06
Feb 19Analysts Just Shaved Their Nu Skin Enterprises, Inc. (NYSE:NUS) Forecasts Dramatically
Feb 18Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Riskier Than It Looks
Jan 18Nu Skin Enterprises (NYSE:NUS) Has A Somewhat Strained Balance Sheet
Dec 14Nu Skin Enterprises (NYSE:NUS) Has Affirmed Its Dividend Of $0.39
Nov 17Nu Skin: Is It Just A Growth Problem?
Oct 17Nu Skin Enterprises (NYSE:NUS) Could Be At Risk Of Shrinking As A Company
Oct 09When Should You Buy Nu Skin Enterprises, Inc. (NYSE:NUS)?
Sep 27Nu Skin: Attractive Valuation Trumps Near-Term Risks
Sep 12Nu Skin Enterprises (NYSE:NUS) Takes On Some Risk With Its Use Of Debt
Sep 08Nu Skin Enterprises (NYSE:NUS) Has Announced A Dividend Of $0.39
Aug 05Is Nu Skin Enterprises, Inc. (NYSE:NUS) Expensive For A Reason? A Look At Its Intrinsic Value
Jul 31Nu Skin: A High-Risk/High-Reward Turnaround Play Worth The Risks
Jun 26Is Now The Time To Look At Buying Nu Skin Enterprises, Inc. (NYSE:NUS)?
Jun 23We Think Nu Skin Enterprises (NYSE:NUS) Is Taking Some Risk With Its Debt
May 22Nu Skin Enterprises (NYSE:NUS) Will Pay A Dividend Of $0.39
May 07Nu Skin Enterprises (NYSE:NUS) Could Be Struggling To Allocate Capital
Apr 26Why Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Worth Watching
Mar 18Nu Skin Enterprises (NYSE:NUS) Will Pay A Larger Dividend Than Last Year At $0.39
Feb 19Nu Skin raises quarterly dividend by 1.3% to $0.39/share
Feb 15CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$103m |
| Jun 30 2024 | n/a | n/a | -US$148m |
| Mar 31 2024 | n/a | n/a | -US$3m |
| Dec 31 2023 | US$6m | US$992k | US$9m |
| Sep 30 2023 | n/a | n/a | US$59m |
| Jun 30 2023 | n/a | n/a | US$70m |
| Mar 31 2023 | n/a | n/a | US$77m |
| Dec 31 2022 | US$5m | US$942k | US$105m |
| Sep 30 2022 | n/a | n/a | US$38m |
| Jun 30 2022 | n/a | n/a | US$113m |
| Mar 31 2022 | n/a | n/a | US$139m |
| Dec 31 2021 | US$5m | US$801k | US$147m |
| Sep 30 2021 | n/a | n/a | US$230m |
| Jun 30 2021 | n/a | n/a | US$237m |
| Mar 31 2021 | n/a | n/a | US$219m |
| Dec 31 2020 | US$4m | US$721k | US$191m |
| Sep 30 2020 | n/a | n/a | US$158m |
| Jun 30 2020 | n/a | n/a | US$146m |
| Mar 31 2020 | n/a | n/a | US$150m |
| Dec 31 2019 | US$2m | US$688k | US$174m |
| Sep 30 2019 | n/a | n/a | US$116m |
| Jun 30 2019 | n/a | n/a | US$125m |
| Mar 31 2019 | n/a | n/a | US$129m |
| Dec 31 2018 | US$3m | US$621k | US$122m |
| Sep 30 2018 | n/a | n/a | US$158m |
| Jun 30 2018 | n/a | n/a | US$146m |
| Mar 31 2018 | n/a | n/a | US$137m |
| Dec 31 2017 | US$3m | US$594k | US$129m |
Compensation vs Market: Ryan's total compensation ($USD5.84M) is above average for companies of similar size in the US market ($USD2.18M).
Compensation vs Earnings: Ryan's compensation has increased whilst the company is unprofitable.
CEO
Ryan Napierski (50 yo)
7.7yrs
Tenure
US$5,838,579
Compensation
Mr. Ryan S. Napierski has been Chief Executive Officer of Nu Skin Enterprises Inc. since September 1, 2021. Mr. Napierski has been the President of Nu Skin Enterprises Inc. since March 7, 2017 and has been...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Executive Chairman of the Board | 28.8yrs | US$856.61k | 0.24% $ 904.8k | |
| President | 7.7yrs | US$5.84m | 0.21% $ 790.9k | |
| Executive VP | 5.3yrs | US$1.86m | 0.14% $ 546.5k | |
| Executive VP & Chief Scientific Officer | 18.8yrs | US$1.12m | 0.19% $ 701.6k | |
| Executive VP & General Counsel | 3.3yrs | US$2.28m | 0.32% $ 1.2m | |
| Executive VP & Chief Product Officer | 6.8yrs | US$1.41m | 0.19% $ 729.7k | |
| Founder | 40.8yrs | US$621.69k | no data | |
| Founder | 28.8yrs | US$1.06m | no data | |
| Senior VP & CTO | 3.8yrs | no data | no data | |
| Chief Information Officer | 18.8yrs | no data | no data | |
| Vice President of Investor Relations | no data | no data | no data | |
| Chief Marketing Officer | 16.5yrs | no data | no data |
12.1yrs
Average Tenure
66yo
Average Age
Experienced Management: NUS's management team is seasoned and experienced (12.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Executive Chairman of the Board | 28.8yrs | US$856.61k | 0.24% $ 904.8k | |
| President | 3.4yrs | US$5.84m | 0.21% $ 790.9k | |
| Independent Director | 9.4yrs | US$273.20k | 0.033% $ 124.9k | |
| Lead Independent Director | 27.7yrs | US$280.20k | 0.21% $ 802.3k | |
| Member of Anti-Aging Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 16.4yrs | US$257.08k | 0.15% $ 547.8k | |
| Member of the Anti-Aging Scientific Advisory Board | 14.8yrs | no data | no data | |
| Member of Anti-Aging Scientific Advisory Board | no data | no data | no data | |
| Member of Anti-aging Scientific Advisory Board | 15.1yrs | no data | no data | |
| Director | 8.3yrs | US$249.20k | 0.044% $ 165.9k | |
| Independent Director | 5.4yrs | US$268.20k | 0.044% $ 164.2k | |
| Independent Director | 3.4yrs | US$264.33k | 0.039% $ 145.9k |
12.1yrs
Average Tenure
67.5yo
Average Age
Experienced Board: NUS's board of directors are seasoned and experienced ( 12.1 years average tenure).